Patrick Maison

770 total citations
40 papers, 475 citations indexed

About

Patrick Maison is a scholar working on General Health Professions, Toxicology and Economics and Econometrics. According to data from OpenAlex, Patrick Maison has authored 40 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in General Health Professions, 10 papers in Toxicology and 10 papers in Economics and Econometrics. Recurrent topics in Patrick Maison's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Patrick Maison is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Patrick Maison collaborates with scholars based in France, Lebanon and Switzerland. Patrick Maison's co-authors include Karima Hider‐Mlynarz, Philippe Cavalié, Adeline Paris, Jean‐Luc Cracowski, Cyndie Picot, Nadine Saleh, Christian Brandt, Luc de Haro, Claire Thalamas and Nathalie Lahoud and has published in prestigious journals such as Frontiers in Pharmacology, British Journal of Clinical Pharmacology and BMJ Open.

In The Last Decade

Patrick Maison

37 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Maison France 12 146 87 68 59 58 40 475
Carrie Fry United States 12 269 1.8× 105 1.2× 105 1.5× 40 0.7× 95 1.6× 33 662
Binaya Sapkota Nepal 13 146 1.0× 50 0.6× 105 1.5× 17 0.3× 60 1.0× 54 523
Robert D. Beckett United States 13 46 0.3× 41 0.5× 44 0.6× 64 1.1× 40 0.7× 46 499
Andrew D. Zechnich United States 12 190 1.3× 65 0.7× 44 0.6× 30 0.5× 39 0.7× 21 863
Abdullah A. Alhifany Saudi Arabia 15 80 0.5× 62 0.7× 39 0.6× 57 1.0× 28 0.5× 61 553
Valentina Petkova Bulgaria 13 30 0.2× 38 0.4× 53 0.8× 53 0.9× 66 1.1× 91 500
Elizabeth Lancaster United States 15 101 0.7× 123 1.4× 40 0.6× 37 0.6× 23 0.4× 56 924
Yahaya Hassan Malaysia 13 36 0.2× 43 0.5× 73 1.1× 28 0.5× 79 1.4× 50 630
Mariagrazia Felisi Italy 14 43 0.3× 149 1.7× 115 1.7× 33 0.6× 442 7.6× 31 828
Harold J. DeMonaco United States 8 47 0.3× 53 0.6× 29 0.4× 25 0.4× 86 1.5× 16 675

Countries citing papers authored by Patrick Maison

Since Specialization
Citations

This map shows the geographic impact of Patrick Maison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Maison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Maison more than expected).

Fields of papers citing papers by Patrick Maison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Maison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Maison. The network helps show where Patrick Maison may publish in the future.

Co-authorship network of co-authors of Patrick Maison

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Maison. A scholar is included among the top collaborators of Patrick Maison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Maison. Patrick Maison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaulent, Marie‐Christine, et al.. (2024). Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities. Frontiers in Pharmacology. 15. 1437167–1437167. 15 indexed citations
2.
3.
Tempia, Stefano, et al.. (2023). Estimation of the influenza‐associated respiratory hospitalization burden using sentinel surveillance data, Lebanon, 2015–2020. Influenza and Other Respiratory Viruses. 17(4). e13138–e13138. 5 indexed citations
4.
Emmerich, Joseph, et al.. (2023). Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience. Frontiers in Public Health. 11. 1293110–1293110. 4 indexed citations
5.
Rizk, Rana, et al.. (2023). Prevalence of medication administration errors in hospitalized adults: A systematic review and meta‐analysis up to 2017 to explore sources of heterogeneity. Fundamental and Clinical Pharmacology. 37(3). 531–548. 2 indexed citations
6.
Cottin, Judith, et al.. (2022). Feasibility study and evaluation of expert opinion on the semi-automated meta-analysis and the conventional meta-analysis. European Journal of Clinical Pharmacology. 78(7). 1177–1184. 10 indexed citations
7.
Benkebil, M., et al.. (2022). Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France. European Journal of Clinical Pharmacology. 79(2). 229–236. 4 indexed citations
8.
Vignot, Stéphane, et al.. (2022). Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority. Frontiers in Pharmacology. 13. 972660–972660.
9.
Valnet‐Rabier, Marie‐Blanche, et al.. (2021). Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet. Pharmacy Practice. 19(2). 2360–2360. 8 indexed citations
10.
Vial, Thierry, et al.. (2021). Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology X. 11. 100128–100128. 10 indexed citations
11.
12.
Lahoud, Nathalie, Rana Rizk, Mira Hleyhel, et al.. (2021). Trends in the consumption of antibiotics in the Lebanese community between 2004 and 2016. International Journal of Clinical Pharmacy. 43(4). 1065–1073. 7 indexed citations
13.
Maison, Patrick, et al.. (2020). The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study. BMJ Open. 10(3). e034033–e034033. 19 indexed citations
14.
Yaacoub, Sally, Nathalie Lahoud, Deema Rahme, et al.. (2019). Antibiotic prescribing for acute uncomplicated cystitis in Lebanese community pharmacies using a simulated patient. Pharmacy Practice. 17(4). 1604–1604. 13 indexed citations
15.
16.
Laroche, Marie‐Laure, et al.. (2016). Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes. Therapies. 71(2). 161–169. 25 indexed citations
17.
Maison, Patrick, et al.. (2013). The public health benefit of medicines: How it has been assessed in France? The principles and results of five years’ experience. Health Policy. 112(3). 273–284. 6 indexed citations
18.
Paris, Adeline, Christian Brandt, Catherine Cornu, et al.. (2009). Informed consent document improvement does not increase patients' comprehension in biomedical research. British Journal of Clinical Pharmacology. 69(3). 231–237. 30 indexed citations
19.
Ngako, A., A. Santin, F. Hémery, et al.. (2009). Prediction of myocardial infarction risk in older patients with acute coronary syndrome. The American Journal of Emergency Medicine. 27(6). 675–682. 6 indexed citations
20.
Paris, Adeline, Catherine Cornu, Patrick Maison, et al.. (2007). Improvement of the comprehension of written information given to healthy volunteers in biomedical research: a single‐blind randomized controlled study. Fundamental and Clinical Pharmacology. 21(2). 207–214. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carrie Fry Breakdown of academic impact, for papers by Binaya Sapkota Breakdown of academic impact, for papers by Robert D. Beckett Breakdown of academic impact, for papers by Andrew D. Zechnich Breakdown of academic impact, for papers by Abdullah A. Alhifany Breakdown of academic impact, for papers by Valentina Petkova Breakdown of academic impact, for papers by Elizabeth Lancaster Breakdown of academic impact, for papers by Yahaya Hassan Breakdown of academic impact, for papers by Mariagrazia Felisi Breakdown of academic impact, for papers by Harold J. DeMonaco
Rankless by CCL
2026